Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Clinical Kidney Journal|December 4, 2023
Risk of chronic kidney disease in patients with acute kidney injury following a major surgery: a US claims database analysisChristoph Ohlmeier, Johannes Schuchhardt, Chris Bauer, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|April 4, 2024
Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and GermanyAlexander Michel, Coralie Lecomte, Christoph Ohlmeier, et al.
Journal of Clinical Medicine|June 19, 2024
Vericiguat Use in Patients with Heart Failure in Real-World Settings during the First Year after the Drug Authorization in JapanSuguru Okami, Christoph Ohlmeier, Makiko Takeichi, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|May 19, 2016
[Percutaneous coronary interventions : Use between 2004 and 2012 in Germany]Christoph Ohlmeier, Jonas Czwikla, Dirk Enders, et al.
Zeitschrift Fur Evidenz, Fortbildung Und Qualitat Im Gesundheitswesen|March 13, 2017
Initiation and duration of dual antiplatelet therapy after inpatient percutaneous coronary intervention with stent implantation in Germany: An electronic healthcare database cohort studyAndres Luque Ramos, Christoph Ohlmeier, Dirk Enders, et al.
Scientific Reports|April 20, 2024
Initiation and continuation of pharmacological therapies in patients hospitalized for heart failure in JapanSuguru Okami, Coralie Lecomte, Hanaya Raad, et al.
International Journal of Cardiology. Heart & Vasculature|March 20, 2026
One-year real-world outcomes after vericiguat initiation in heart failure: The ROVER-Japan cohort studyMakiko Takeichi, Shun Kohsaka, Kotaro Nochioka, et al.
Pageof 3